Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.
- DOI
- 10.1177/25158414261477639
- Published
- 2026 Jan-Dec
- Container
- Therapeutic advances in ophthalmology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/25158414261477639,
title = {Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.},
author = {Singer MA and Wykoff CC and Riemann CD and Gonzalez VH and Weng CY and Alkhatib K and Moody S and Pao M},
year = {2026},
journal = {Therapeutic advances in ophthalmology},
doi = {10.1177/25158414261477639},
url = {https://doi.org/10.1177/25158414261477639}
}RIS
TY - JOUR TI - Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. AU - Singer MA AU - Wykoff CC AU - Riemann CD AU - Gonzalez VH AU - Weng CY AU - Alkhatib K AU - Moody S AU - Pao M PY - 2026 JO - Therapeutic advances in ophthalmology DO - 10.1177/25158414261477639 UR - https://doi.org/10.1177/25158414261477639 ER -
APA
MA, S., CC, W., CD, R., VH, G., CY, W., K, A., S, M., & M, P. (2026). Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.. Therapeutic advances in ophthalmology. https://doi.org/10.1177/25158414261477639
Source records
- pubmed · retrieved 2026-11-10T13:22:21.625Z